N1-guanyl-1,7-diaminoheptane (GC7) enhances the therapeutic efficacy of doxorubicin by inhibiting activation of eukaryotic translation initiation factor 5A2 (eIF5A2) and preventing the epithelial–mesenchymal transition in hepatocellular carcinoma cells |
| |
摘 要: |
|
收稿时间: | 2013-03-13 |
修稿时间: | 2013-07-09 |
本文献已被 ScienceDirect 等数据库收录! |
|